Which hedge funds own CTVA? CORTEVA INC, Q2 2026 13F holders
Basic Materials · Open on the interactive board
13 of the hedge funds tracked by WhaleCreep disclosed a position in CTVA (CORTEVA INC) in their Q2 2026 13F filings, worth $1.1bn in total. The largest holder by portfolio weight is Scopia Capital Management at 7.9% of its book. 2 managers opened a new position this quarter: Bridgewater Associates, Holocene Advisors. 3 exited: Brevan Howard Capital Management, Marshall Wace, Renaissance Technologies LLC.
13tracked managers holding
2opened this quarter
3exited this quarter
Which hedge funds hold CTVA? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Scopia Capital Management | Q2 2026 | 7.9% | $8.9m | 104,675 | -29% | reduced |
| Bronte Capital | Q2 2026 | 4.4% | $38.7m | 456,656 | -9% | reduced |
| Anomaly Capital Management | Q2 2026 | 3.9% | $101.8m | 1,201,753 | 14% | added |
| WCM Investment Management | Q2 2026 | 1.0% | $745.3m | 8,939,948 | 3% | added |
| Bridgewater Associates | Q2 2026 | 0.1% | $20.6m | 243,050 | – | new |
| Millennium Management | Q2 2026 | 0.1% | $111.0m | 1,310,524 | 123% | added |
| Citadel Advisors | Q2 2026 | 0.0% | $73.3m | 865,225 | 364% | added |
| Ancora Advisors | Q2 2026 | 0.0% | $1.4m | 16,690 | -5% | reduced |
| Point72 Asset Management LP | Q2 2026 | 0.0% | $15.5m | 183,340 | 699% | added |
| Woodline Partners | Q2 2026 | 0.0% | $7.0m | 83,165 | 506% | added |
| Holocene Advisors | Q2 2026 | 0.0% | $3.7m | 43,110 | – | new |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $10.6m | 125,655 | -56% | reduced |
| First Manhattan | Q2 2026 | 0.0% | $385.3k | 4,550 | -63% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Brevan Howard Capital Management | 0.1% | $737.7k |
| Marshall Wace | 0.3% | $11.4m |
| Renaissance Technologies LLC | 0.0% | $1.2m |
How has hedge fund ownership of CTVA changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 13 | $1.1bn |
| Q1 2026 | 14 | $973.3m |
| Q4 2025 | 8 | $909.9m |
| Q3 2025 | 10 | $1.0bn |
| Q2 2025 | 10 | $1.1bn |
| Q1 2025 | 12 | $864.3m |
| Q4 2024 | 14 | $1.0bn |
| Q3 2024 | 11 | $1.2bn |
| Q2 2024 | 11 | $1.1bn |
| Q1 2024 | 11 | $1.1bn |
| Q4 2023 | 11 | $876.3m |
| Q3 2023 | 11 | $682.6m |
| Q2 2023 | 11 | $554.8m |
| Q1 2023 | 12 | $621.0m |
| Q4 2022 | 10 | $479.7m |
| Q3 2022 | 13 | $343.6m |
Counts every tracked manager that disclosed CTVA in that quarter's filing, including managers that have since stopped filing.